Literature DB >> 7472540

[Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions].

I Berry1, J F Gaillard, Z Guo, Y S Cordoliani, P Massip, C Manelfe, B Danet.   

Abstract

CT and MRI are not consistently able to differentiate central nervous system (CNS) lymphoma from focal cerebral infection such as toxoplasmosis in the human immunodeficiency virus (HIV) involvement. In this study thallium 201 (and/or technetium-MIBI) SPECT was performed in 6 patients suffering from AIDS and CNS lesions. An index based on the ratio of thallium uptake in the lesion vs the contralateral scalp was calculated. In 4 out of 5 patients with lymphoma (3 confirmed by biopsy, 2 highly suspected on CT and resistance to antitoxoplasmosis treatment) focal lesions showed high uptake of thallium. On the other hand one markedly necrotic lymphoma and all infectious lesions did not take up thallium. This suggests a role for thallium 201 brain SPECT in the workup of focal CNS lesions in AIDS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472540

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  2 in total

1.  Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients.

Authors:  Robert J Young; Munir V Ghesani; Nolan J Kagetsu; Andrew J Derogatis
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis.

Authors:  C Shyam babu; P Satishchandra; A Mahadevan; V Pillai Shibu; S Ravishankar; N Sidappa; R Udaykumar; V Ravi; S K Shankar
Journal:  Clin Neurol Neurosurg       Date:  2012-11-12       Impact factor: 1.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.